Popular Articles

FDA Accepts For Review Spectrum's Response On ZEVALIN As A Class 1 Submission, And Establishes September 7, 2009 As Decision Date
Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage biotechnology company with a focus on oncology, announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the resubmission to the Company"s supplement to the biologics license application for ZEVALIN (ibritumomab tiuxetan) in the first line consolidation setting on July 8, 2009. The FDA considers the review as a Class 1 submission to their complete response letter of July 2, 2009. Therefore, the user fee goal date is September 7, 2009.
generic viagra
Scientist First To Characterize Novel Syndrome Of Allergy, Apraxia, Malabsorption
A landmark study conducted by Children"s Hospital & Research Center Oakland is the first to reveal a new syndrome in children that presents with a combination of allergy, apraxia and malabsorption. Autism spectrum disorders were variably present. Verbal apraxia has until now been understood to be a neurologically based speech disorder, although hints of other neurological soft signs have been described. The new study, led by Children"s Hospital & Research Center Oakland scientist and pediatric emergency medicine physician, Claudia Morris, MD, and Marilyn C. Agin, MD, a neurodevelopmental pediatrician at Saint Vincent Medical Center in New York, however, suggests that the symptoms of verbal apraxia are, at least for a sub-group of children, part of a larger, multifactorial, neurologic syndrome involving food allergies/gluten-sensitivity and nutritional malabsorption.
News of the day
÷£16 Million Demonstrator Sites For Breaks, Healthchecks And Better Support From The NHS, UK
Carers across the country will be given better access to healthchecks, more support from the NHS and more opportunities to take time off thanks to a ÷£16 million demonstration programme announced by Care Services Minister Phil Hope today.

HSE Warns Businesses Not To Be Misled Over New Law Poster, UK.

The Health and Safety Executive (HSE) is warning businesses across Britain not to be duped into buying unnecessary and overpriced copies of its health and safety law poster. The poster is a fixture of every workplace in Britain and employers have a legal duty to display the poster in a prominent position or provide each worker with a copy of a Law pocket card. Both outline employer and workers responsibilities and where workers can seek advice. There is some evidence of misleading promotions wrongly claiming that the old poster must be replaced immediately and that the new law poster should be displayed on every notice board within the business" premises. This is incorrect and employers could be led to believe that they are not meeting their legal requirements.

Steroid Abuse Leads To Alarming Rise In Hair Loss Victims.

Men are being warned that steroids can lead to premature baldness after a leading hair clinic reported an alarming rise in the number of patients affected by the designer drugs. Optima Hair Specialists - which supplies advanced hair replacement systems - has seen a 60 per cent increase* in enquiries from men who have taken anabolic-androgenic steroids (AAS) and suffered early hair loss as a result. AAS are believed to stimulate Dihydrotestosterone** (DHT) - a powerful sex hormone that triggers baldness in men***. Peter Murtha, founder of Optima Hair Specialists, said: "It is widely accepted that DHT has an adverse affect on hair follicles and is the main culprit behind male pattern baldness. Recent studies have found that steroid drugs can increase the levels of DHT within the body and therefore accelerate hair loss. Vibration machines FAQ

Application Of Innovative Laser Research Could Lead To Earlier Bone Disorder Diagnosis.

A new laser technique that could lead to bone disorders being diagnosed earlier is to be tested in a hospital for the first time. The study, which it"s hoped will pave the way for future clinical trials, will apply a revolutionary approach known as SORS (Spatially Offset Raman Spectroscopy), to examine specific substances in non see-through surfaces deeper than has previously been possible, without damaging the surface. The research team hope ultimately that the method can be used both to detect and screen for early signs of diseases such as osteoarthritis and osteoporosis.

Sugar Substitute Appears To Prevent Early-Childhood Cavities.

Children given an oral syrup containing the naturally occurring sweetener xylitol may be less likely to develop decay in their baby teeth, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals. Early childhood caries (cavities), also called baby bottle tooth decay or nursing caries, continue to increase in prevalence, according to background information in the article. "Poor children experience rates twice as high as those of their more affluent peers, and their disease is more likely to be untreated," the authors write.